Your browser doesn't support javascript.
loading
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
Logue, Jennifer M; Peres, Lauren C; Hashmi, Hamza; Colin-Leitzinger, Christelle M; Shrewsbury, Alexandria M; Hosoya, Hitomi; Gonzalez, Rebecca M; Copponex, Christina; Kottra, Krista H; Hovanky, Vanna; Sahaf, Bita; Patil, Sunita; Lazaryan, Aleksandr; Jain, Michael D; Baluch, Aliyah; Klinkova, Olga V; Bejanyan, Nelli; Faramand, Rawan G; Elmariah, Hany; Khimani, Farhad; Davila, Marco L; Mishra, Asmita; Blue, Brandon J; Grajales-Cruz, Ariel F; Castaneda Puglianini, Omar A; Liu, Hien D; Nishihori, Taiga; Freeman, Ciara L; Brayer, Jason B; Shain, Kenneth H; Baz, Rachid C; Locke, Frederick L; Alsina, Melissa; Sidana, Surbhi; Hansen, Doris K.
Affiliation
  • Logue JM; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Peres LC; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Hashmi H; Division of Hematology and Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC.
  • Colin-Leitzinger CM; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Shrewsbury AM; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Hosoya H; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Gonzalez RM; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Copponex C; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Kottra KH; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Hovanky V; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Patil S; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Lazaryan A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Baluch A; Division of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Klinkova OV; Division of Infectious Diseases, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Faramand RG; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Elmariah H; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Khimani F; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Davila ML; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Mishra A; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Blue BJ; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Grajales-Cruz AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Castaneda Puglianini OA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Liu HD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Brayer JB; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Baz RC; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Alsina M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Blood Adv ; 6(24): 6109-6119, 2022 12 27.
Article in En | MEDLINE | ID: mdl-35939783
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombocytopenia / Receptors, Chimeric Antigen / Anemia / Multiple Myeloma Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombocytopenia / Receptors, Chimeric Antigen / Anemia / Multiple Myeloma Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Adv Year: 2022 Type: Article